The growth of the mastoid volume in children with a cochlear implant.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 07 2023
Historique:
received: 05 04 2022
accepted: 16 06 2023
medline: 10 7 2023
pubmed: 7 7 2023
entrez: 6 7 2023
Statut: epublish

Résumé

The aim of this study was to understand the mastoid volume development in children who undergo cochlear implantation surgery. Cochlear implant (CI) database of our clinic (Kuopio University Hospital) was reviewed for computed tomography (CT) images of CI patients (age under 12 years at the time of implantation) with a minimum time interval of twelve months between their pre- and postoperative CT. Eight patients (nine ears) were found eligible for inclusion. Three linear measurements were taken by using picture archiving and communication systems (PACS) software and the volume of the MACS was measured with Seg 3D software. The mastoid volume increased on average 817.5 mm

Identifiants

pubmed: 37414822
doi: 10.1038/s41598-023-37160-7
pii: 10.1038/s41598-023-37160-7
pmc: PMC10325979
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10967

Informations de copyright

© 2023. The Author(s).

Références

Arkh Anat Gistol Embriol. 1977;72(1):76-82
pubmed: 869726
Cochlear Implants Int. 2011 Aug;12(3):177-80
pubmed: 21917207
J Laryngol Otol. 1990 Aug;104(8):603-5
pubmed: 2230550
Eur Arch Otorhinolaryngol. 2009 Jun;266(6):781-6
pubmed: 19283403
Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1411-8
pubmed: 26164294
Front Surg. 2022 Mar 24;9:823219
pubmed: 35402479
Surg Radiol Anat. 2019 Feb;41(2):221-225
pubmed: 30415274
Ann Saudi Med. 2005 Jan-Feb;25(1):41-5
pubmed: 15822493
Ear Nose Throat J. 2022 Jul 21;:1455613221106221
pubmed: 35861389
Am J Otol. 2000 Jan;21(1):49-56
pubmed: 10651435
HNO. 2009 Jul;57(7):663-70
pubmed: 19554272
Otol Neurotol. 2020 Jun;41(5):709-714
pubmed: 32080026
Otol Neurotol. 2008 Feb;29(2):156-9
pubmed: 18090097
Otol Neurotol. 2017 Jun;38(5):721-729
pubmed: 28207625
Trends Amplif. 2010 Mar;14(1):46-57
pubmed: 20483813

Auteurs

Minna Tirkkonen (M)

Department of Otorhinolaryngology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. minnatir@student.uef.fi.

Matti Iso-Mustajärvi (M)

Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland.

Anandhan Dhanasingh (A)

Head of Translational Science Communication, MED-EL, Innsbruck, Austria.

Pia Linder (P)

Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland.

Katariina Myller (K)

Department of Oncology, Vaasa Central Hospital, Vaasa, Finland.
Department of Radiology, Turku University Hospital, Turku, Finland.

Aarno Dietz (A)

Department of Otorhinolaryngology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH